taurine has been researched along with Disorders of Excessive Somnolence in 3 studies
Disorders of Excessive Somnolence: Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)
| Excerpt | Relevance | Reference |
|---|---|---|
| "beta-Alanine is a central-nervous-system depressant." | 5.24 | Hyper-beta-alaninemia associated with beta-aminoaciduria and gamma-aminobutyricaciduria, somnolence and seizures. ( Davies, E; Pueschel, S; Scriver, CR, 1966) |
| "Homotaurine is a natural compound of red algae, which has been demonstrated to have a neuroprotective effect and has been evaluated as a possible therapeutic agent for Alzheimer's disease." | 2.80 | Homotaurine in Parkinson's disease. ( De Nigris, F; Fasano, A; Ricciardi, L; Specchia, A, 2015) |
| "Taurine treatment limited mitochondrial superoxide generation, supporting a role for taurine in maintaining complex I activity." | 1.43 | Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia. ( Alexeyev, M; Jong, CJ; Mehdi, AB; Schaffer, SW; Shetewy, A; Shimada-Takaura, K; Takahashi, K; Warner, D, 2016) |
| "beta-Alanine is a central-nervous-system depressant." | 1.24 | Hyper-beta-alaninemia associated with beta-aminoaciduria and gamma-aminobutyricaciduria, somnolence and seizures. ( Davies, E; Pueschel, S; Scriver, CR, 1966) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ricciardi, L | 1 |
| De Nigris, F | 1 |
| Specchia, A | 1 |
| Fasano, A | 1 |
| Shetewy, A | 1 |
| Shimada-Takaura, K | 1 |
| Warner, D | 1 |
| Jong, CJ | 1 |
| Mehdi, AB | 1 |
| Alexeyev, M | 1 |
| Takahashi, K | 1 |
| Schaffer, SW | 1 |
| Scriver, CR | 1 |
| Pueschel, S | 1 |
| Davies, E | 1 |
1 trial available for taurine and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Homotaurine in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Disorders of Excessive Somnolence; Female; Humans; | 2015 |
2 other studies available for taurine and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia.
Topics: Animals; beta-Alanine; Disorders of Excessive Somnolence; Electron Transport Complex I; Embryo, Mamm | 2016 |
Hyper-beta-alaninemia associated with beta-aminoaciduria and gamma-aminobutyricaciduria, somnolence and seizures.
Topics: 4-Aminobutyrate Transaminase; Amino Acid Metabolism, Inborn Errors; beta-Alanine; Disorders of Exces | 1966 |